Impact and Outcomes of Pretreatment Total Serum Testosterone on Localized Prostate Cancer Patients

Impact and Outcomes of Pretreatment Total Serum Testosterone on Localized Prostate Cancer Patients

Purpose. To investigate how pretreatment testosterone levels correlate with progression-free survival, metastasis-free survival, and overall survival in a propensity-adjusted localized prostate cancer population. Methods. Men diagnosed with clinical NCCN-risk stratified very-low, low, intermediate,...

Full description

Bibliographic Details
Main Authors:	Brittni M. Usera, Polly Creveling, Jonathan D. Tward
Format:	Article
Language:	English
Published:	Hindawi Limited 2020-01-01
Series:	Prostate Cancer
Online Access:	http://dx.doi.org/10.1155/2020/8357452

Similar Items

Serum Testosterone Level, Testosterone Replacement Treatment, and Prostate Cancer
by: Ali Atan, et al.
Published: (2013-01-01)

Pretreatment tumor volume estimation based on total serum psa in patients with localized prostate cancer
by: Raphael Barroso Kato, et al.
Published: (2008-01-01)

Relationship between serum total testosterone and prostate volume in aging men
by: Bo-Wen Xia, et al.
Published: (2021-07-01)

Impact of Pretreatment Total Cholesterol Level Is Associated With Metastasis of Prostate Cancer
by: Hisashi Hirano, et al.
Published: (2020-04-01)

Impact of the level of testosterone on the development of cancer of the prostate
by: A. V. Pechersky, et al.
Published: (2020-02-01)

Total testosterone in young men is more closely associated than free testosterone with prostate cancer disparities
by: Louis Calistro Alvarado
Published: (2011-06-01)

Low levels of serum testosterone in middle-aged men impact pathological features of prostate cancer
by: Elton Llukani, et al.
Published: (2017-03-01)

The role of serum testosterone to prostate-specific antigen ratio as a predictor of prostate cancer risk
by: Cenk Gurbuz, et al.
Published: (2012-12-01)

Testosterone replacement and prostate cancer
by: Ranjith Ramasamy, et al.
Published: (2012-01-01)

CORRELATION BETWEEN SERUM TESTOSTERONE, BIOCHEMICAL AND CLINICAL MARKERS IN PROSTATE CANCER PATIENTS
by: Bogdan Roussev, et al.
Published: (2016-09-01)

Low serum testosterone is a predictor of high-grade disease in patients with prostate cancer
by: George A. M. Lins de Albuquerque, et al.

Low serum testosterone predicts upgrading and upstaging of prostate cancer after radical prostatectomy
by: Yuan Gao, et al.
Published: (2016-01-01)

Accuracy of serum luteinizing hormone and serum testosterone measurements to assess the efficacy of medical castration in prostate cancer patients
by: Juan Morote, et al.
Published: (2017-10-01)

Serum Total Testosterone and Premature Mortality Among Men in the USA
by: Richard J. Fantus, et al.
Published: (2021-07-01)

PROGNOSTIC VALUE OF THE BASELINE VALUES OF SERUM TESTOSTERONE AND FREE ANDROGEN INDEX IN PATIENTS WITH PROSTATE CANCER
by: M. E. Grigoryev, et al.
Published: (2014-08-01)

Neoadjuvant androgen-deprivation therapy with radical prostatectomy for prostate cancer in association with age and serum testosterone
by: Naoko Akitake, et al.
Published: (2018-09-01)

PROGNOSTIC VALUE OF THE BASELINE VALUES OF SERUM TESTOSTERONE AND FREE ANDROGEN INDEX IN PATIENTS WITH PROSTATE CANCER
by: M. E. Grigoryev, et al.
Published: (2014-08-01)

Testosterone treatment and the risk of aggressive prostate cancer in men with low testosterone levels.
by: Thomas J Walsh, et al.
Published: (2018-01-01)

COMPARATIVE ESTIMATION OF THE PROGNOSTIC VALUE OF THE BASELINE VALUES OF SERUM TESTOSTERONE AND PROSTATE-SPECIFIC ANTIGEN IN PATIENTS WITH SUSPECTED PROSTATE CANCER
by: M. E. Grigoryev, et al.
Published: (2014-07-01)

COMPARATIVE ESTIMATION OF THE PROGNOSTIC VALUE OF THE BASELINE VALUES OF SERUM TESTOSTERONE AND PROSTATE-SPECIFIC ANTIGEN IN PATIENTS WITH SUSPECTED PROSTATE CANCER
by: M. E. Grigoryev, et al.
Published: (2014-07-01)

Testosterone replacement therapy and the risk of prostate cancer
by: Daniel Warburton, et al.
Published: (2015-01-01)

The role of the serum testosterone levels as a predictor of prostate cancer in patients with atypical small acinar proliferation at the first prostate biopsy
by: Lucio Dell′Atti, et al.
Published: (2018-01-01)

The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy
by: Antonio B. Porcaro, et al.
Published: (2016-03-01)

Prognostic role of docetaxel-induced suppression of free testosterone serum levels in metastatic prostate cancer patients
by: Paula Kappler, et al.
Published: (2021-08-01)

Serum testosterone level predicts the effective time of androgen deprivation therapy in metastatic prostate cancer patients
by: Yue Wang, et al.
Published: (2017-01-01)

Effect of Citrullus lanatus Seeds Extracts on Serum Total Testosterone in Rat
by: Khaki Arash, et al.
Published: (2014-01-01)

Male Accessory Gland Infection: Relevance of Serum Total Testosterone Levels
by: R. A. Condorelli, et al.
Published: (2014-01-01)

Shifting the Paradigm of Testosterone Replacement Therapy in Prostate Cancer
by: Michael A. Bell, et al.
Published: (2018-05-01)

Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408
by: R. Charles Nichols, MD, et al.
Published: (2017-10-01)

Higher Serum Testosterone Levels Associated with Favorable Prognosis in Enzalutamide- and Abiraterone-Treated Castration-Resistant Prostate Cancer
by: Shinichi Sakamoto, et al.
Published: (2019-04-01)

Testosterone and benign prostatic hyperplasia
by: Thomas R Jarvis, et al.
Published: (2015-04-01)

The association of pretreatment serum albumin with outcomes in bladder cancer: a meta-analysis
by: Li J, et al.
Published: (2018-06-01)

Variation in Serum Total Testosterone Levels in Men with Type 2 Diabetes Mellitus
by: Jyoti Trivedi, et al.
Published: (2019-06-01)

Premature decline of serum total testosterone in HIV-infected men in the HAART-era.
by: Vincenzo Rochira, et al.
Published: (2011-01-01)

Correlation between testosterone level, serum prostate-specific antigen level, and diabetes mellitus with grade inflammation of the prostate
by: A.A G.A. Anom A Wiradana, et al.
Published: (2019-06-01)

Effect of a Combination of Dutasteride and Parenteral Testosterone Undecanoate on Testosterone Deficiency Symptoms and Prostate in Patients with Testosterone Efficiency and Benign Prostatic Hyperplasia
by: Min Gu Park, et al.
Published: (2020-06-01)

Low serum testosterone levels in patients with breast cancer
by: Om Agrawal, et al.
Published: (2014-01-01)

The effects of aging on serum testosterone, testosterone-binding and serum gonadotropin levels in human males
by: Stearns, Eric Lewis
Published: (2012)

The effects of aging on serum testosterone, testosterone-binding and serum gonadotropin levels in human males
by: Stearns, Eric Lewis
Published: (2012)

Could Testosterone Have a Therapeutic Role in Prostate Cancer?
by: Konstantinos Stamatiou
Published: (2013-03-01)

Cannot write session to /tmp/vufind_sessions/sess_hpk9att4pivffg24p19h116hp3